¼¼°èÀÇ ÇコÄɾî¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå ¿¹Ãø(-2032³â) : Àç·áº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®
3D Printing in Healthcare Market Forecasts to 2032 - Global Analysis By Material (Polymers, Ceramics, Metals, Hydrogels and Bioinks, and Biocompatible Materials), Technology, Application, End User and By Geography
»óǰÄÚµå : 1822367
¸®¼­Ä¡»ç : Stratistics Market Research Consulting
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200+ Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,150 £Ü 5,880,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,439,000
PDF (2-5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,350 £Ü 8,998,000
PDF & Excel (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇÕ´Ï´Ù. Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,628,000
PDF & Excel (Global Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 10ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ÇコÄɾî¿ë 3D ÇÁ¸°ÆÃ ½ÃÀåÀº 2025³â¿¡ 19¾ï 9,000¸¸ ´Þ·¯¸¦ Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ Áß CAGR 20.03%·Î ¼ºÀåÇϸç, 2032³â¿¡´Â 71¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ 3D ÇÁ¸°ÆÃÀº ȯÀÚ ¸ÂÃãÇü ÀÇ·á Á¦Ç°, ¸ðµ¨, ±â±â¸¦ Á¦ÀÛÇϱâ À§ÇÑ ºÎ°¡ÀûÀÎ Á¦Á¶ ±â¼úÀÇ »ç¿ëÀ» ÀǹÌÇÕ´Ï´Ù. ¸ÂÃãÇü ÀÓÇöõÆ®, º¸Ã¶¹°, ¼ö¼ú °èȹ¿ë ÇØºÎÇÐ ¸ðµ¨, ¹ÙÀÌ¿ÀÇÁ¸°ÆÃµÈ Á¶Á÷ ¹× Àå±âÀÇ Á¦Á¶¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. 3D ÇÁ¸°ÆÃÀº Á¤¹Ð¼º, °³ÀÎÈ­, ½Å¼ÓÇÑ ÇÁ·ÎÅäŸÀÌÇÎÀ» ÅëÇØ ¸ÂÃãÇü ÀÇ·á ¹× Àç»ýÀÇ·á ¼Ö·ç¼ÇÀÇ Çõ½ÅÀ» ÃËÁøÇϰí, ÀÇ·á ¼­ºñ½º¸¦ Çõ½ÅÇϰí, Ä¡·á °á°ú¸¦ °³¼±Çϰí, ºñ¿ëÀ» Àý°¨ÇÏ´Â µî ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.

½ºÆ®¶óŸ½Ã½º¿¡ µû¸£¸é J5 Digital Anatomy´Â ȯÀÚ °á°ú¸¦ °³¼±Çϰí, ¼ö¼ú ÀýÂ÷ÀÇ È¿À²¼ºÀ» ³ôÀ̸ç, ÇØºÎÇÐ Á¦Ç° ½ÃÀå Ãâ½Ã¸¦ °¡¼ÓÈ­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

ÇコÄÉ¾î ºÐ¾ß¿¡¼­´Â ȯÀÚ ¸ÂÃãÇü Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϸ鼭 3D ÇÁ¸°ÆÃ ±â¼ú µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÓÇöõÆ®, º¸Ã¶¹°, ÇØºÎÇÐ ¸ðµ¨Àº º¸´Ù Á¤È®ÇÑ ¼ö¼ú °èȹ°ú ÀÓ»ó °á°ú °³¼±À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ°ú Á¶Á÷°øÇÐÀÇ ¹ßÀüÀ¸·Î ¸ÂÃãÇü ÀÇ·áÀÇ ¹üÀ§°¡ ³Ð¾îÁö°í ÀÖ½À´Ï´Ù. º´¿øÀº AI ±â¹Ý ¼³°è Ç÷§ÆûÀ» ÅëÇÕÇÏ¿© ȯÀÚ °³°³ÀÎÀÇ ÇØºÎÇÐÀû ±¸Á¶¿¡ ¸Â´Â ÀåÄ¡¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â Á¾¾çÇÐ, Á¤Çü¿Ü°ú, Àç°Ç¿Ü°ú¿¡¼­ ƯÈ÷ µÎµå·¯Áý´Ï´Ù. Á¤¹ÐÀÇ·á°¡ Á¡Á¡ ´õ ź·ÂÀ» ¹ÞÀ¸¸é¼­ 3D ÇÁ¸°ÆÃÀº Â÷¼¼´ë Ä¡·á Àü·«ÀÇ Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë Àμ⿡ »ç¿ëÇÒ ¼ö ÀÖ´Â Àç·á´Â ÇÑÁ¤µÇ¾î ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë °íºÐÀÚ ¹× ±Ý¼Ó¿¡ ´ëÇÑ ±ÔÁ¦ ±âÁØÀº ¾ö°ÝÇÏ°í ±¤¹üÀ§ÇÑ °ËÁõ°ú Å×½ºÆ®°¡ ÇÊ¿äÇÕ´Ï´Ù. »ýüÈí¼ö¼º º¹ÇÕÀç·á, Ç×±Õ¼º Çʶó¸àÆ® µîÀÇ ½Å±â¼úÀº À¯¸ÁÇÏÁö¸¸ ¾ÆÁ÷ ³Î¸® »ó¿ëÈ­µÇÁö´Â ¾Ê¾Ò½À´Ï´Ù. ¼Ò±Ô¸ð Á¦Á¶¾÷ü´Â ½ÂÀÎµÈ Àç·á¸¦ Á¶´ÞÇÏ´Â µ¥ ¾î·Á¿òÀ» °Þ°í ÀÖÀ¸¸ç, ÀÌ´Â ±â¼ú Çõ½Å°ú ½ÃÀå ÁøÀÔÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. Ư¼ö ¼ÒÀç°ø±Þ¸ÁÀÌ Ç¥ÁØÈ­µÇ¾î ÀÖÁö ¾Ê´Ù´Â Á¡ÀÌ »ý»êÀÇ È®À强À» ´õ¿í º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. º¸´Ù ±¤¹üÀ§ÇÑ Àç·á Æ÷Æ®Æú¸®¿À°¡ °³¹ßµÇ°í ÀÎÁõµÉ ¶§±îÁö ÀÓ»ó Àû¿ëÀÇ ¼ºÀåÀº ¾ïÁ¦µÉ °ÍÀÔ´Ï´Ù.

Ä¡°ú ¹× Á¤Çü¿Ü°ú ºÐ¾ß äÅà Ȯ´ë

ȯÀÚ ¸ÂÃãÇü ºÎǰÀ» °íÁ¤¹Ðµµ·Î Á¦ÀÛÇÒ ¼ö ÀÖ°Ô µÇ¸é¼­ ½Ã¼ú ¿öÅ©Ç÷ο찡 Å©°Ô º¯È­Çϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Ä¡°ú¿¡¼­´Â ±¸°­³» ½ºÄ³³Ê¿Í CAD/CAM ½Ã½ºÅÛÀ» Ȱ¿ëÇÏ¿© Å©¶ó¿î°ú ºê¸´Áö Á¦ÀÛÀ» °£¼ÒÈ­Çϰí ÀÖ½À´Ï´Ù. Á¤Çü¿Ü°ú ÀÇ»çµéÀº ȸº¹°ú ÀûÇÕ¼ºÀ» ³ôÀ̱â À§ÇØ ÀμâµÈ »À ºñ°è¿Í Àΰø °üÀýÀ» »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÎ¼â Æ¼Å¸´½°ú PEEK ÀÓÇöõÆ®¿¡ ´ëÇÑ ±ÔÁ¦ ½ÂÀÎÀº ÀÌ·¯ÇÑ ºÐ¾ß¿¡¼­ÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. Àç·á°úÇаú ¿µ»ó±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ÀÌµé ºÐ¾ß´Â ÀÓ»óÀû ÅëÇÕÀ» °è¼Ó ÁÖµµÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

µðÁöÅÐ ¼³°è ÆÄÀÏÀÇ »çÀ̹ö º¸¾È À§Çè

ÇコÄɾî Á¦Á¶ÀÇ µðÁöÅÐÈ­´Â ¼³°è ÆÄÀÏÀÇ ¹«°á¼º ¹× µ¥ÀÌÅÍ º¸¾È¿¡ Ãë¾à¼ºÀ» °¡Á®¿É´Ï´Ù. ȯÀÚº° CAD ¸ðµ¨¿¡ ´ëÇÑ ¹«´Ü ¾×¼¼½º´Â ±â¹Ð¼º°ú ±â±âÀÇ Á¤È®¼ºÀ» ¼Õ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. º´¿ø°ú Á¦Á¶¾÷üµéÀº µðÁöÅÐ ÀÚ»êÀ» º¸È£Çϱâ À§ÇØ ºí·ÏüÀΰú ¾Ïȣȭ ÇÁ·ÎÅäÄÝÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¼³°è ¸®Æ÷ÁöÅ丮¸¦ °Ü³ÉÇÑ »çÀ̹ö °ø°ÝÀº »ý»ê ¿¬¼Ó¼º ¹× ±ÔÁ¦ Áؼö¿¡ À§ÇèÀ» ÃÊ·¡ÇÕ´Ï´Ù. IoT Áö¿ø ÇÁ¸°ÅÍ¿Í ¿ø°Ý ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ÅëÇÕÀº »çÀ̹ö À§Çù¿¡ ´õ ¸¹Àº ³ëÃâÀ» °¡Á®¿É´Ï´Ù. °ß°íÇÑ »çÀ̹ö º¸¾È ÇÁ·¹ÀÓ¿öÅ©°¡ ¾ø´Ù¸é, 3D ÇÁ¸°ÆÃ ÀÇ·á±â±âÀÇ ½Å·Ú¼º°ú ¾ÈÀü¼ºÀÌ ÈÑ¼ÕµÉ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19´Â Àü ¼¼°è °ø±Þ¸ÁÀ» È¥¶õ¿¡ ºü¶ß¸®°í ¼±ÅÃÀû ½Ã¼úÀ» Áö¿¬½ÃÅ´À¸·Î½á ÀÓ»ó ÇöÀå¿¡¼­ÀÇ 3D ÇÁ¸°ÆÃ µµÀÔÀÌ ÀϽÃÀûÀ¸·Î Áö¿¬µÇ¾ú½À´Ï´Ù. ±×·¯³ª À̹ø À§±â´Â ¸éºÀÀ̳ª ÀΰøÈ£Èí±â ºÎǰ°ú °°Àº ÀÀ±ÞÀÇ·á¿ëǰ Á¦Á¶¿¡ ÀÖÀ¸¸ç, ÀûÃþ ¼ºÇüÀÇ À¯¿¬¼ºÀ» ºÎ°¢½ÃÄ×½À´Ï´Ù. ±ÔÁ¦±â°üÀº ÀμâµÈ PPE ¹× Áø´Ü Åø¿¡ ´ëÇÑ ½Å¼ÓÇÑ ½ÂÀÎÀ» µµÀÔÇÏ¿© ½ÃÀå ÀÎÁöµµ¸¦ ³ô¿´½À´Ï´Ù. Æ÷½ºÆ® Äڷγª Àü·«Àº ±âÁ¸ °ø±Þ¸Á¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß±â À§ÇØ Åº·Â¼º, ÀÚµ¿È­, ÇöÁö »ý»ê¿¡ ÁßÁ¡À» µÎ°Ô µÇ¾ú½À´Ï´Ù. COVID-19´Â °á±¹ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí, ÀÇ·á ºÐ¾ß¿¡¼­ 3D ÇÁ¸°ÆÃÀÇ ¿ªÇÒÀ» È®´ëÇß½À´Ï´Ù.

¿¹Ãø ±â°£ Áß Æú¸®¸Ó ºÎ¹®ÀÌ °¡Àå Å« ºÎ¹®ÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Æú¸®¸Ó ºÐ¾ß´Â ¹ü¿ë¼º°ú ºñ¿ë È¿À²¼ºÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. PLA, ABS, PEEK¿Í °°Àº »ýüÀûÇÕ¼º Æú¸®¸Ó´Â º¸Ã¶, ¼ö¼ú ¸ðµ¨, Ä¡°ú¿ëÀ¸·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °íºÐÀÚ È­ÇÐÀÇ ²÷ÀÓ¾ø´Â ¹ßÀüÀ¸·Î ´õ ³ªÀº ±â°èÀû Ư¼º°ú ¸ê±Õ ÀûÇÕ¼ºÀÌ °¡´ÉÇØÁö°í ÀÖ½À´Ï´Ù. º´¿ø¿¡¼­´Â °¡º±°í »ç¿ëÀÚ Á¤Àǰ¡ ½¬¿î Æú¸®¸Ó ±â¹Ý ±â±¸¸¦ ¼±È£Çϰí ÀÖ½À´Ï´Ù. »õ·Î¿î µ¿ÇâÀ¸·Î´Â Ç×±Õ ÄÚÆÃ, ´Ü±â°£ ÀÓÇöõÆ®¿ëÀ¸·Î Á¶Á¤µÈ »ýºÐÇØ¼º Á¦Á¦ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. Àç·áÀÇ ±â¼ú Çõ½ÅÀÌ ÁøÇàµÊ¿¡ µû¶ó Æú¸®¸Ó´Â ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ¼Ö·ç¼ÇÀÇ ±Ù°£ÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¿¹Ãø ±â°£ Áß º´¿ø ¹× ¼ö¼ú¼¾ÅÍ ºÎ¹®Àº °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿¹Ãø ±â°£ Áß º´¿ø ¹× ¼ö¼ú¼¾ÅÍ ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌµé º´¿ø¿¡¼­´Â ¼ö¼ú Àü °èȹÀ̳ª ȯÀÚ ±³À°¿¡ ÀμâµÈ ÇØºÎÇÐ ¸ðµ¨À» »ç¿ëÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. AI ±â¹Ý ¼³°è ¼ÒÇÁÆ®¿þ¾îÀÇ ÅëÇÕÀ¸·Î ¼ö¼ú±â±¸ ¹× ÀÓÇöõÆ®ÀÇ ½Å¼ÓÇÑ ÇÁ·ÎÅäŸÀÌÇÎÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á¿Í ÃÖ¼Ò Ä§½À ¼ö¼ú·ÎÀÇ ÀüȯÀÌ ¸ÂÃãÇü ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. º´¿øÀº ¶ÇÇÑ Á¶´Þ ¸®µå ŸÀÓÀ» ´ÜÃàÇϰí ÀýÂ÷ÀÇ È¿À²¼ºÀ» ³ôÀ̱â À§ÇØ º´¿ø³» Àμ⠽ÇÇè½Ç¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó ¿öÅ©Ç÷ο찡 ÁøÈ­ÇÔ¿¡ µû¶ó 3D ÇÁ¸°ÆÃÀº ¼ö¼ú Çõ½ÅÀÇ ÇÙ½É ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À² Áö¿ª:

¿¹Ãø ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÀÎÇÁ¶ó¿Í ±â¼ú¿¡ ´ëÇÑ È°¹ßÇÑ ÅõÀÚ¿¡ ÈûÀÔ¾î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áß±¹, Àεµ, Çѱ¹ µîÀÇ ±¹°¡µéÀº ÀÇ·á±â±âÀÇ ÇöÁö »ý»ê ´É·ÂÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎ ±¸»óÀº º¸Á¶±Ý°ú ¹Î°ü ÆÄÆ®³Ê½ÊÀ» ÅëÇØ µðÁöÅÐ ÇコÄɾî¿Í ¼öÀÔ ´ëü¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â 3D ÇÁ¸°ÆÃ ÅøÀ» ±â¹ÝÀ¸·Î ÇÑ AI Áö¿ø Áø´Ü°ú ·Îº¿ ¼ö¼úÀÌ ºü¸£°Ô µµÀԵǰí ÀÖ½À´Ï´Ù. ¼¼°è OEM°ú Áö¿ª ±â¾÷°úÀÇ Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ±â¼ú ÀÌÀü°ú ½ÃÀå ħÅõ°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¼ö¼ú °Ç¼ö Áõ°¡¿Í Áß»êÃþ Áõ°¡·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áö¼ÓÀûÀÎ ¸®´õ½ÊÀ» È®º¸ÇÒ ¼ö Àִ ż¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¿¹Ãø ±â°£ Áß ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â °­·ÂÇÑ R&D »ýŰè¿Í ÷´Ü ±â¼úÀÇ Á¶±â µµÀÔ¿¡ ÈûÀÔÀº °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù´Â ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ, ½º¸¶Æ® ÀÓÇöõÆ®, AI ÅëÇÕ ¼³°è Ç÷§Æû ºÐ¾ß¿¡¼­ Çõ½ÅÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦±â°üÀº Àμâ ÀÇ·á±â±âÀÇ ½ÂÀÎ °æ·Î¸¦ °£¼ÒÈ­ÇÏ¿© º¸´Ù ºü¸¥ »ó¿ëÈ­¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. º´¿øÀº IoT¿Í Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛÀ» Ȱ¿ëÇÏ¿© 3D ÇÁ¸°ÆÃ ¿öÅ©Ç÷οì¿Í Àç°í °ü¸®¸¦ ÃÖÀûÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ¼º¼÷ÇÑ »óȯ ü°è¿Í ¸ÂÃã Ä¡·á¿¡ ´ëÇÑ ³ôÀº ¼ö¿äÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ ¼­ºñ½º:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ¼­¹®

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

Á¦4Àå Porters Five Force ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ÇコÄɾî¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå : Àç·áº°

Á¦6Àå ¼¼°èÀÇ ÇコÄɾî¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå : ±â¼úº°

Á¦7Àå ¼¼°èÀÇ ÇコÄɾî¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå : ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ ÇコÄɾî¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°èÀÇ ÇコÄɾî¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå : Áö¿ªº°

Á¦10Àå ÁÖ¿ä ¹ßÀü

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

According to Stratistics MRC, the Global 3D Printing in Healthcare Market is accounted for $1.99 billion in 2025 and is expected to reach $7.15 billion by 2032 growing at a CAGR of 20.03% during the forecast period. 3D printing in healthcare refers to the use of additive manufacturing technologies to create patient-specific medical products, models, and devices. It enables the production of customized implants, prosthetics, anatomical models for surgical planning, and even bioprinted tissues and organs. By offering precision, personalization, and faster prototyping, 3D printing is transforming healthcare delivery, improving treatment outcomes, and reducing costs while advancing innovations in personalized medicine and regenerative healthcare solutions.

According to Stratasys, J5 Digital Anatomy seeks to improve patient outcomes, increase the efficiency of operating procedures and accelerate the market availability of anatomical products.

Market Dynamics:

Driver:

Growing demand for personalized medical solutions

The healthcare sector is witnessing a surge in demand for patient-specific treatments, driving the adoption of 3D printing technologies. Custom implants, prosthetics, and anatomical models are enabling more precise surgical planning and improved clinical outcomes. Advances in bio-printing and tissue engineering are expanding the scope of personalized medicine. Hospitals are integrating AI-driven design platforms to tailor devices to individual patient anatomies. This shift is particularly prominent in oncology, orthopedics, and reconstructive surgery. As precision medicine gains momentum, 3D printing is becoming central to next-generation therapeutic strategies.

Restraint:

Limited material availability for medical-grade printing

Regulatory standards for medical-grade polymers and metals are stringent, requiring extensive validation and testing. Emerging technologies like bioresorbable composites and antimicrobial filaments are promising but not yet widely commercialized. Smaller manufacturers face challenges in sourcing approved materials, limiting innovation and market entry. The lack of standardized supply chains for specialty materials further complicates production scalability. Until broader material portfolios are developed and certified, growth in clinical applications will remain constrained.

Opportunity:

Increasing adoption in dental and orthopedic sectors

The ability to produce patient-specific components with high precision is transforming procedural workflows. Digital dentistry is leveraging intraoral scanners and CAD/CAM systems to streamline crown and bridge fabrication. Orthopedic surgeons are using printed bone scaffolds and joint replacements to enhance recovery and fit. Regulatory approvals for printed titanium and PEEK implants are accelerating adoption in these segments. As material science and imaging technologies evolve, these sectors will continue to lead in clinical integration.

Threat:

Cybersecurity risks in digital design files

The digitization of healthcare manufacturing introduces vulnerabilities in design file integrity and data security. Unauthorized access to patient-specific CAD models can compromise confidentiality and device accuracy. Hospitals and manufacturers are increasingly deploying blockchain and encryption protocols to safeguard digital assets. Cyberattacks targeting cloud-based design repositories pose risks to production continuity and regulatory compliance. The integration of IoT-enabled printers and remote monitoring systems adds further exposure to cyber threats. Without robust cybersecurity frameworks, the reliability and safety of 3D-printed medical devices may be jeopardized.

Covid-19 Impact

The pandemic disrupted global supply chains and delayed elective procedures, temporarily slowing the adoption of 3D printing in clinical settings. However, the crisis also highlighted the flexibility of additive manufacturing in producing emergency medical supplies like swabs and ventilator components. Regulatory bodies introduced fast-track approvals for printed PPE and diagnostic tools, boosting market visibility. Post-COVID strategies now emphasize resilience, automation, and localized manufacturing to reduce dependency on traditional supply chains. The pandemic ultimately catalyzed innovation and broadened the role of 3D printing in healthcare preparedness.

The polymers segment is expected to be the largest during the forecast period

The polymers segment is expected to account for the largest market share during the forecast period, due to its versatility and cost-effectiveness. Biocompatible polymers such as PLA, ABS, and PEEK are widely used in prosthetics, surgical models, and dental applications. Continuous advancements in polymer chemistry are enabling better mechanical properties and sterilization compatibility. Hospitals prefer polymer-based devices for their lightweight nature and ease of customization. Emerging trends include antimicrobial coatings and biodegradable formulations tailored for short-term implants. As material innovation progresses, polymers will remain the backbone of medical 3D printing solutions.

The hospitals & surgical centres segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals & surgical centres segment is predicted to witness the highest growth rate. These facilities are increasingly using printed anatomical models for preoperative planning and patient education. Integration of AI-powered design software is enabling rapid prototyping of surgical tools and implants. The shift toward personalized care and minimally invasive procedures is driving demand for custom devices. Hospitals are also investing in in-house printing labs to reduce procurement lead times and enhance procedural efficiency. As clinical workflows evolve, 3D printing is becoming a core component of surgical innovation.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by robust investments in medical infrastructure and technology. Countries like China, India, and South Korea are expanding local manufacturing capabilities for medical devices. Government initiatives are promoting digital healthcare and import substitution through subsidies and public-private partnerships. The region is witnessing rapid adoption of AI-assisted diagnostics and robotic surgery, supported by 3D-printed tools. Strategic collaborations between global OEMs and regional players are accelerating technology transfer and market penetration. With rising surgical volumes and a growing middle class, Asia Pacific is poised for sustained leadership.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by strong R&D ecosystems and early adoption of advanced technologies. The U.S. and Canada are pioneering innovations in bioprinting, smart implants, and AI-integrated design platforms. Regulatory agencies are streamlining approval pathways for printed medical devices, encouraging faster commercialization. Hospitals are leveraging IoT and cloud-based systems to optimize 3D printing workflows and inventory management. The region benefits from a mature reimbursement framework and high demand for personalized treatments.

Key players in the market

Some of the key players profiled in the 3D Printing in Healthcare Market include Stratasys Ltd., Prodways Group, 3D Systems Inc., Anatomics Pty Ltd, Materialise NV, CELLINK, EOS GmbH, Zortrax S.A., Renishaw PLC, SLM Solutions Group AG, Organovo Holdings Inc., Arcam AB, EnvisionTEC GmbH, Nanoscribe GmbH & Co. KG, and Oxford Performance Materials.

Key Developments:

In July 2025, Stratasys Ltd. announced the commercial launch of P3(TM) Silicone 25A, a high-performance material developed through a strategic collaboration with Shin-Etsu, a global leader in silicone science. Designed exclusively for the Stratasys Origin(R) DLP platform, this general-purpose silicone enables production of flexible parts that match the performance of traditionally molded silicone.

In October 2024, Prodways introduces the DENTAL PRO Series, a cutting-edge range of 3D printers designed specifically for the dental industry, aiming to transform the workflow of dental laboratories by enhancing productivity, precision, and versatility.

Materials Covered:

Technologies Covered:

Applications Covered:

End Users Covered:

Regions Covered:

What our report offers:

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Table of Contents

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global 3D Printing in Healthcare Market, By Material

6 Global 3D Printing in Healthcare Market, By Technology

7 Global 3D Printing in Healthcare Market, By Application

8 Global 3D Printing in Healthcare Market, By End User

9 Global 3D Printing in Healthcare Market, By Geography

10 Key Developments

11 Company Profiling

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â